The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Matuzumab (formerly known as the experimental drug, EMD 72000) is a humanized monoclonal antibody used in cancer treatment. It has a high affinity for EGFR (epithelial growth factor receptor), frequently associated with the growth of blood vessels in malignancy, facilitating tumor growth and survival.
The global Matuzumab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Matuzumab is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Matuzumab is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Matuzumab include Biosynth Carbosynth, BOC Sciences, Carbosynth, Merck KGaA, Shanghai Yifei Biotechnology, Takeda Pharmaceutical, TargetMol Chemicals, Wonda Science and Hangzhou Dayangchem, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Matuzumab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Matuzumab.
Report Scope
The Matuzumab market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Matuzumab market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Matuzumab manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biosynth Carbosynth
BOC Sciences
Carbosynth
Merck KGaA
Shanghai Yifei Biotechnology
Takeda Pharmaceutical
TargetMol Chemicals
Wonda Science
Hangzhou Dayangchem
Leap Chem
Nantong Feiyu Biological Technology
Ningbo Inno Pharmchem
Sichuan Weiqi Biotechnology
Segment by Type
Patent
Generic
Segment by Application
Chemical
Pharmaceutical
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Matuzumab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Matuzumab in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Matuzumab (formerly known as the experimental drug, EMD 72000) is a humanized monoclonal antibody used in cancer treatment. It has a high affinity for EGFR (epithelial growth factor receptor), frequently associated with the growth of blood vessels in malignancy, facilitating tumor growth and survival.
The global Matuzumab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Matuzumab is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Matuzumab is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Matuzumab include Biosynth Carbosynth, BOC Sciences, Carbosynth, Merck KGaA, Shanghai Yifei Biotechnology, Takeda Pharmaceutical, TargetMol Chemicals, Wonda Science and Hangzhou Dayangchem, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Matuzumab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Matuzumab.
Report Scope
The Matuzumab market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Matuzumab market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Matuzumab manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biosynth Carbosynth
BOC Sciences
Carbosynth
Merck KGaA
Shanghai Yifei Biotechnology
Takeda Pharmaceutical
TargetMol Chemicals
Wonda Science
Hangzhou Dayangchem
Leap Chem
Nantong Feiyu Biological Technology
Ningbo Inno Pharmchem
Sichuan Weiqi Biotechnology
Segment by Type
Patent
Generic
Segment by Application
Chemical
Pharmaceutical
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Matuzumab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Matuzumab in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Matuzumab Market Overview
1.1 Product Overview and Scope of Matuzumab
1.2 Matuzumab Segment by Type
1.2.1 Global Matuzumab Market Value Comparison by Type (2024-2030)
1.2.2 Patent
1.2.3 Generic
1.3 Matuzumab Segment by Application
1.3.1 Global Matuzumab Market Value by Application: (2024-2030)
1.3.2 Chemical
1.3.3 Pharmaceutical
1.4 Global Matuzumab Market Size Estimates and Forecasts
1.4.1 Global Matuzumab Revenue 2019-2030
1.4.2 Global Matuzumab Sales 2019-2030
1.4.3 Global Matuzumab Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Matuzumab Market Competition by Manufacturers
2.1 Global Matuzumab Sales Market Share by Manufacturers (2019-2024)
2.2 Global Matuzumab Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Matuzumab Average Price by Manufacturers (2019-2024)
2.4 Global Matuzumab Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Matuzumab, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Matuzumab, Product Type & Application
2.7 Matuzumab Market Competitive Situation and Trends
2.7.1 Matuzumab Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Matuzumab Players Market Share by Revenue
2.7.3 Global Matuzumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Matuzumab Retrospective Market Scenario by Region
3.1 Global Matuzumab Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Matuzumab Global Matuzumab Sales by Region: 2019-2030
3.2.1 Global Matuzumab Sales by Region: 2019-2024
3.2.2 Global Matuzumab Sales by Region: 2025-2030
3.3 Global Matuzumab Global Matuzumab Revenue by Region: 2019-2030
3.3.1 Global Matuzumab Revenue by Region: 2019-2024
3.3.2 Global Matuzumab Revenue by Region: 2025-2030
3.4 North America Matuzumab Market Facts & Figures by Country
3.4.1 North America Matuzumab Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Matuzumab Sales by Country (2019-2030)
3.4.3 North America Matuzumab Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Matuzumab Market Facts & Figures by Country
3.5.1 Europe Matuzumab Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Matuzumab Sales by Country (2019-2030)
3.5.3 Europe Matuzumab Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Matuzumab Market Facts & Figures by Country
3.6.1 Asia Pacific Matuzumab Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Matuzumab Sales by Country (2019-2030)
3.6.3 Asia Pacific Matuzumab Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Matuzumab Market Facts & Figures by Country
3.7.1 Latin America Matuzumab Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Matuzumab Sales by Country (2019-2030)
3.7.3 Latin America Matuzumab Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Matuzumab Market Facts & Figures by Country
3.8.1 Middle East and Africa Matuzumab Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Matuzumab Sales by Country (2019-2030)
3.8.3 Middle East and Africa Matuzumab Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Matuzumab Sales by Type (2019-2030)
4.1.1 Global Matuzumab Sales by Type (2019-2024)
4.1.2 Global Matuzumab Sales by Type (2025-2030)
4.1.3 Global Matuzumab Sales Market Share by Type (2019-2030)
4.2 Global Matuzumab Revenue by Type (2019-2030)
4.2.1 Global Matuzumab Revenue by Type (2019-2024)
4.2.2 Global Matuzumab Revenue by Type (2025-2030)
4.2.3 Global Matuzumab Revenue Market Share by Type (2019-2030)
4.3 Global Matuzumab Price by Type (2019-2030)
5 Segment by Application
5.1 Global Matuzumab Sales by Application (2019-2030)
5.1.1 Global Matuzumab Sales by Application (2019-2024)
5.1.2 Global Matuzumab Sales by Application (2025-2030)
5.1.3 Global Matuzumab Sales Market Share by Application (2019-2030)
5.2 Global Matuzumab Revenue by Application (2019-2030)
5.2.1 Global Matuzumab Revenue by Application (2019-2024)
5.2.2 Global Matuzumab Revenue by Application (2025-2030)
5.2.3 Global Matuzumab Revenue Market Share by Application (2019-2030)
5.3 Global Matuzumab Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Biosynth Carbosynth
6.1.1 Biosynth Carbosynth Corporation Information
6.1.2 Biosynth Carbosynth Description and Business Overview
6.1.3 Biosynth Carbosynth Matuzumab Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Biosynth Carbosynth Matuzumab Product Portfolio
6.1.5 Biosynth Carbosynth Recent Developments/Updates
6.2 BOC Sciences
6.2.1 BOC Sciences Corporation Information
6.2.2 BOC Sciences Description and Business Overview
6.2.3 BOC Sciences Matuzumab Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BOC Sciences Matuzumab Product Portfolio
6.2.5 BOC Sciences Recent Developments/Updates
6.3 Carbosynth
6.3.1 Carbosynth Corporation Information
6.3.2 Carbosynth Description and Business Overview
6.3.3 Carbosynth Matuzumab Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Carbosynth Matuzumab Product Portfolio
6.3.5 Carbosynth Recent Developments/Updates
6.4 Merck KGaA
6.4.1 Merck KGaA Corporation Information
6.4.2 Merck KGaA Description and Business Overview
6.4.3 Merck KGaA Matuzumab Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck KGaA Matuzumab Product Portfolio
6.4.5 Merck KGaA Recent Developments/Updates
6.5 Shanghai Yifei Biotechnology
6.5.1 Shanghai Yifei Biotechnology Corporation Information
6.5.2 Shanghai Yifei Biotechnology Description and Business Overview
6.5.3 Shanghai Yifei Biotechnology Matuzumab Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Shanghai Yifei Biotechnology Matuzumab Product Portfolio
6.5.5 Shanghai Yifei Biotechnology Recent Developments/Updates
6.6 Takeda Pharmaceutical
6.6.1 Takeda Pharmaceutical Corporation Information
6.6.2 Takeda Pharmaceutical Description and Business Overview
6.6.3 Takeda Pharmaceutical Matuzumab Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Takeda Pharmaceutical Matuzumab Product Portfolio
6.6.5 Takeda Pharmaceutical Recent Developments/Updates
6.7 TargetMol Chemicals
6.6.1 TargetMol Chemicals Corporation Information
6.6.2 TargetMol Chemicals Description and Business Overview
6.6.3 TargetMol Chemicals Matuzumab Sales, Revenue and Gross Margin (2019-2024)
6.4.4 TargetMol Chemicals Matuzumab Product Portfolio
6.7.5 TargetMol Chemicals Recent Developments/Updates
6.8 Wonda Science
6.8.1 Wonda Science Corporation Information
6.8.2 Wonda Science Description and Business Overview
6.8.3 Wonda Science Matuzumab Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Wonda Science Matuzumab Product Portfolio
6.8.5 Wonda Science Recent Developments/Updates
6.9 Hangzhou Dayangchem
6.9.1 Hangzhou Dayangchem Corporation Information
6.9.2 Hangzhou Dayangchem Description and Business Overview
6.9.3 Hangzhou Dayangchem Matuzumab Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hangzhou Dayangchem Matuzumab Product Portfolio
6.9.5 Hangzhou Dayangchem Recent Developments/Updates
6.10 Leap Chem
6.10.1 Leap Chem Corporation Information
6.10.2 Leap Chem Description and Business Overview
6.10.3 Leap Chem Matuzumab Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Leap Chem Matuzumab Product Portfolio
6.10.5 Leap Chem Recent Developments/Updates
6.11 Nantong Feiyu Biological Technology
6.11.1 Nantong Feiyu Biological Technology Corporation Information
6.11.2 Nantong Feiyu Biological Technology Matuzumab Description and Business Overview
6.11.3 Nantong Feiyu Biological Technology Matuzumab Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Nantong Feiyu Biological Technology Matuzumab Product Portfolio
6.11.5 Nantong Feiyu Biological Technology Recent Developments/Updates
6.12 Ningbo Inno Pharmchem
6.12.1 Ningbo Inno Pharmchem Corporation Information
6.12.2 Ningbo Inno Pharmchem Matuzumab Description and Business Overview
6.12.3 Ningbo Inno Pharmchem Matuzumab Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Ningbo Inno Pharmchem Matuzumab Product Portfolio
6.12.5 Ningbo Inno Pharmchem Recent Developments/Updates
6.13 Sichuan Weiqi Biotechnology
6.13.1 Sichuan Weiqi Biotechnology Corporation Information
6.13.2 Sichuan Weiqi Biotechnology Matuzumab Description and Business Overview
6.13.3 Sichuan Weiqi Biotechnology Matuzumab Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Sichuan Weiqi Biotechnology Matuzumab Product Portfolio
6.13.5 Sichuan Weiqi Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Matuzumab Industry Chain Analysis
7.2 Matuzumab Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Matuzumab Production Mode & Process
7.4 Matuzumab Sales and Marketing
7.4.1 Matuzumab Sales Channels
7.4.2 Matuzumab Distributors
7.5 Matuzumab Customers
8 Matuzumab Market Dynamics
8.1 Matuzumab Industry Trends
8.2 Matuzumab Market Drivers
8.3 Matuzumab Market Challenges
8.4 Matuzumab Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Matuzumab Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Matuzumab Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Matuzumab Market Competitive Situation by Manufacturers in 2023
Table 4. Global Matuzumab Sales (Kg) of Key Manufacturers (2019-2024)
Table 5. Global Matuzumab Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Matuzumab Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Matuzumab Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Matuzumab Average Price (US$/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Matuzumab, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Matuzumab, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Matuzumab, Product Type & Application
Table 12. Global Key Manufacturers of Matuzumab, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Matuzumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Matuzumab as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Matuzumab Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Matuzumab Sales by Region (2019-2024) & (Kg)
Table 18. Global Matuzumab Sales Market Share by Region (2019-2024)
Table 19. Global Matuzumab Sales by Region (2025-2030) & (Kg)
Table 20. Global Matuzumab Sales Market Share by Region (2025-2030)
Table 21. Global Matuzumab Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Matuzumab Revenue Market Share by Region (2019-2024)
Table 23. Global Matuzumab Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Matuzumab Revenue Market Share by Region (2025-2030)
Table 25. North America Matuzumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Matuzumab Sales by Country (2019-2024) & (Kg)
Table 27. North America Matuzumab Sales by Country (2025-2030) & (Kg)
Table 28. North America Matuzumab Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Matuzumab Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Matuzumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Matuzumab Sales by Country (2019-2024) & (Kg)
Table 32. Europe Matuzumab Sales by Country (2025-2030) & (Kg)
Table 33. Europe Matuzumab Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Matuzumab Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Matuzumab Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Matuzumab Sales by Region (2019-2024) & (Kg)
Table 37. Asia Pacific Matuzumab Sales by Region (2025-2030) & (Kg)
Table 38. Asia Pacific Matuzumab Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Matuzumab Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Matuzumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Matuzumab Sales by Country (2019-2024) & (Kg)
Table 42. Latin America Matuzumab Sales by Country (2025-2030) & (Kg)
Table 43. Latin America Matuzumab Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Matuzumab Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Matuzumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Matuzumab Sales by Country (2019-2024) & (Kg)
Table 47. Middle East & Africa Matuzumab Sales by Country (2025-2030) & (Kg)
Table 48. Middle East & Africa Matuzumab Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Matuzumab Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Matuzumab Sales (Kg) by Type (2019-2024)
Table 51. Global Matuzumab Sales (Kg) by Type (2025-2030)
Table 52. Global Matuzumab Sales Market Share by Type (2019-2024)
Table 53. Global Matuzumab Sales Market Share by Type (2025-2030)
Table 54. Global Matuzumab Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Matuzumab Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Matuzumab Revenue Market Share by Type (2019-2024)
Table 57. Global Matuzumab Revenue Market Share by Type (2025-2030)
Table 58. Global Matuzumab Price (US$/Kg) by Type (2019-2024)
Table 59. Global Matuzumab Price (US$/Kg) by Type (2025-2030)
Table 60. Global Matuzumab Sales (Kg) by Application (2019-2024)
Table 61. Global Matuzumab Sales (Kg) by Application (2025-2030)
Table 62. Global Matuzumab Sales Market Share by Application (2019-2024)
Table 63. Global Matuzumab Sales Market Share by Application (2025-2030)
Table 64. Global Matuzumab Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Matuzumab Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Matuzumab Revenue Market Share by Application (2019-2024)
Table 67. Global Matuzumab Revenue Market Share by Application (2025-2030)
Table 68. Global Matuzumab Price (US$/Kg) by Application (2019-2024)
Table 69. Global Matuzumab Price (US$/Kg) by Application (2025-2030)
Table 70. Biosynth Carbosynth Corporation Information
Table 71. Biosynth Carbosynth Description and Business Overview
Table 72. Biosynth Carbosynth Matuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 73. Biosynth Carbosynth Matuzumab Product
Table 74. Biosynth Carbosynth Recent Developments/Updates
Table 75. BOC Sciences Corporation Information
Table 76. BOC Sciences Description and Business Overview
Table 77. BOC Sciences Matuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 78. BOC Sciences Matuzumab Product
Table 79. BOC Sciences Recent Developments/Updates
Table 80. Carbosynth Corporation Information
Table 81. Carbosynth Description and Business Overview
Table 82. Carbosynth Matuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 83. Carbosynth Matuzumab Product
Table 84. Carbosynth Recent Developments/Updates
Table 85. Merck KGaA Corporation Information
Table 86. Merck KGaA Description and Business Overview
Table 87. Merck KGaA Matuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 88. Merck KGaA Matuzumab Product
Table 89. Merck KGaA Recent Developments/Updates
Table 90. Shanghai Yifei Biotechnology Corporation Information
Table 91. Shanghai Yifei Biotechnology Description and Business Overview
Table 92. Shanghai Yifei Biotechnology Matuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 93. Shanghai Yifei Biotechnology Matuzumab Product
Table 94. Shanghai Yifei Biotechnology Recent Developments/Updates
Table 95. Takeda Pharmaceutical Corporation Information
Table 96. Takeda Pharmaceutical Description and Business Overview
Table 97. Takeda Pharmaceutical Matuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 98. Takeda Pharmaceutical Matuzumab Product
Table 99. Takeda Pharmaceutical Recent Developments/Updates
Table 100. TargetMol Chemicals Corporation Information
Table 101. TargetMol Chemicals Description and Business Overview
Table 102. TargetMol Chemicals Matuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 103. TargetMol Chemicals Matuzumab Product
Table 104. TargetMol Chemicals Recent Developments/Updates
Table 105. Wonda Science Corporation Information
Table 106. Wonda Science Description and Business Overview
Table 107. Wonda Science Matuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 108. Wonda Science Matuzumab Product
Table 109. Wonda Science Recent Developments/Updates
Table 110. Hangzhou Dayangchem Corporation Information
Table 111. Hangzhou Dayangchem Description and Business Overview
Table 112. Hangzhou Dayangchem Matuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 113. Hangzhou Dayangchem Matuzumab Product
Table 114. Hangzhou Dayangchem Recent Developments/Updates
Table 115. Leap Chem Corporation Information
Table 116. Leap Chem Description and Business Overview
Table 117. Leap Chem Matuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 118. Leap Chem Matuzumab Product
Table 119. Leap Chem Recent Developments/Updates
Table 120. Nantong Feiyu Biological Technology Corporation Information
Table 121. Nantong Feiyu Biological Technology Description and Business Overview
Table 122. Nantong Feiyu Biological Technology Matuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 123. Nantong Feiyu Biological Technology Matuzumab Product
Table 124. Nantong Feiyu Biological Technology Recent Developments/Updates
Table 125. Ningbo Inno Pharmchem Corporation Information
Table 126. Ningbo Inno Pharmchem Description and Business Overview
Table 127. Ningbo Inno Pharmchem Matuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 128. Ningbo Inno Pharmchem Matuzumab Product
Table 129. Ningbo Inno Pharmchem Recent Developments/Updates
Table 130. Sichuan Weiqi Biotechnology Corporation Information
Table 131. Sichuan Weiqi Biotechnology Description and Business Overview
Table 132. Sichuan Weiqi Biotechnology Matuzumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 133. Sichuan Weiqi Biotechnology Matuzumab Product
Table 134. Sichuan Weiqi Biotechnology Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Matuzumab Distributors List
Table 138. Matuzumab Customers List
Table 139. Matuzumab Market Trends
Table 140. Matuzumab Market Drivers
Table 141. Matuzumab Market Challenges
Table 142. Matuzumab Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Matuzumab
Figure 2. Global Matuzumab Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Matuzumab Market Share by Type in 2023 & 2030
Figure 4. Patent Product Picture
Figure 5. Generic Product Picture
Figure 6. Global Matuzumab Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Matuzumab Market Share by Application in 2023 & 2030
Figure 8. Chemical
Figure 9. Pharmaceutical
Figure 10. Global Matuzumab Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Matuzumab Market Size (2019-2030) & (US$ Million)
Figure 12. Global Matuzumab Sales (2019-2030) & (Kg)
Figure 13. Global Matuzumab Average Price (US$/Kg) & (2019-2030)
Figure 14. Matuzumab Report Years Considered
Figure 15. Matuzumab Sales Share by Manufacturers in 2023
Figure 16. Global Matuzumab Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Matuzumab Players: Market Share by Revenue in 2023
Figure 18. Matuzumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Matuzumab Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Matuzumab Sales Market Share by Country (2019-2030)
Figure 21. North America Matuzumab Revenue Market Share by Country (2019-2030)
Figure 22. United States Matuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Matuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Matuzumab Sales Market Share by Country (2019-2030)
Figure 25. Europe Matuzumab Revenue Market Share by Country (2019-2030)
Figure 26. Germany Matuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Matuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Matuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Matuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Matuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Matuzumab Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Matuzumab Revenue Market Share by Region (2019-2030)
Figure 33. China Matuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Matuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Matuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Matuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Matuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Matuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Matuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Matuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Matuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Matuzumab Sales Market Share by Country (2019-2030)
Figure 43. Latin America Matuzumab Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Matuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Matuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Matuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Matuzumab Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Matuzumab Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Matuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Matuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Matuzumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Matuzumab by Type (2019-2030)
Figure 53. Global Revenue Market Share of Matuzumab by Type (2019-2030)
Figure 54. Global Matuzumab Price (US$/Kg) by Type (2019-2030)
Figure 55. Global Sales Market Share of Matuzumab by Application (2019-2030)
Figure 56. Global Revenue Market Share of Matuzumab by Application (2019-2030)
Figure 57. Global Matuzumab Price (US$/Kg) by Application (2019-2030)
Figure 58. Matuzumab Value Chain
Figure 59. Matuzumab Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
